Illuminating the druggable genome through patent bioactivity data
The patent literature is a potentially valuable source of bioactivity data. In this article we describe a process to prioritise 3.7 million life science relevant patents obtained from the SureChEMBL database (https://www.surechembl.org/), according to how likely they were to contain bioactivity data...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-05-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/15153.pdf |